Cogent Private Wealth’s Merck MRK Stock Holding History

Cogent Private Wealth’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$272K	Buy	+2,260	New	+$261K	0.2%	78

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cogent Private Wealth's MRK Position: Q1 2026 in Review

Cogent Private Wealth opened a new position in Merck (MRK) in Q1 2026: 2,260 shares worth $272K. The stake represents 0.2% of the portfolio and ranks #78 among its holdings.

3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Cogent Private Wealth held 2,260 shares of Merck worth $272K as of Q1 2026.
Merck was a new Cogent Private Wealth position in Q1 2026.
Merck made up 0.2% of Cogent Private Wealth's portfolio in Q1 2026, its #78 holding.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cogent Private Wealth's 13F filing for Q1 2026, filed 13 Apr 2026.